sorafenib has been researched along with Actinic Reticuloid Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, A; Lacouture, ME; Laumann, AE; Petronic-Rosic, V; Ratain, MJ; Soltani, K; Stadler, WM | 1 |
1 other study(ies) available for sorafenib and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.
Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Humans; Keratosis; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Photosensitivity Disorders; Protein Kinase Inhibitors; Pyridines; Sorafenib | 2006 |